RecruitingNCT06333587

Minimally Invasive Treatments of the Thyroid

Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma


Sponsor

European Institute of Oncology

Enrollment

270 participants

Start Date

Oct 10, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating minimally invasive treatments (such as thermal ablation or other non-surgical options) for small papillary thyroid cancers, as an alternative to traditional open surgery. Researchers want to track patient outcomes using these less invasive approaches. **You may be eligible if...** - You are over 18 years old - You have been diagnosed with papillary thyroid microcarcinoma (a small, low-risk type of thyroid cancer) confirmed by biopsy - Your cancer is suitable for a minimally invasive treatment rather than full surgery - You are able and willing to attend follow-up appointments **You may NOT be eligible if...** - Your tumor is larger than 1 cm - You have a bleeding disorder that cannot be managed - You have a psychiatric condition that prevents you from giving informed consent - You prefer or require open surgical treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREimage-guided thermal ablation

image-guided thermal ablation in patients with diagnosis of micropapillary thyroid carcinoma


Locations(1)

European Institute of Oncology

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06333587


Related Trials